Friday, April 24, 2026
Home Authors Posts by Ogkologos

Ogkologos

4204 POSTS 0 COMMENTS

One Year of Adjuvant T-DM1 Leads to Outstanding Long-Term Outcomes Among...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Olaparib to Patients with...

Ogkologos -
0

PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients...

Ogkologos -
0

FDA Grants Accelerated Approval to Adagrasib with Cetuximab for KRAS G12C-mutated...

Ogkologos -
0

Second- or Third-Line Treatment with Tisotumab Vedotin Results in Greater Efficacy...

Ogkologos -
0

A Meaningful Benefit of the Quadruplet-Based Isatuximab Plus VRd Regimen in...

Ogkologos -
0

Lorlatinib Slows Growth of ALK-Positive Lung Cancers, May Prevent Brain Metastases

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Erdafitinib

Ogkologos -
0

Trial Establishes Preferred Treatment for Some People with Esophageal Cancer

Ogkologos -
0

Adjuvant Dabrafenib Plus Trametinib Associated with Better RFS and DMFS than...

Ogkologos -
0
1...575859...421Page 58 of 421

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com